GPCR 内幕交易
GPCR 的 SEC Form 4 内幕交易记录
总交易
78
买入
0
买入总额
-
卖出总额
$6.6M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(35) | FMR LLC | - | 卖出 | 16,085 | $50.07 | $805K | 2026-07-22 | 大股东(>10%)卖出, 大额卖出(>$500K) |
| ★★★★★(35) | FMR LLC | - | 卖出 | 16,085 | $55.07 | $886K | 2026-04-14 | 大股东(>10%)卖出, 大额卖出(>$500K) |
| ★★★★★(30) | FMR LLC | - | 卖出 | 1,367 | $50.07 | $68K | 2026-07-22 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(30) | FMR LLC | - | 卖出 | 1,367 | $55.07 | $75K | 2026-04-14 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(27) | FMR LLC | - | 卖出 | 6,498 | $84.22 | $547K | 2026-01-15 | 大股东(>10%)卖出, 大额卖出(>$500K) |
| ★★★★★(23) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 4,008 | $36.15 | $145K | 2026-09-21 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 4,539 | $47.20 | $214K | 2026-09-01 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 100 | $47.83 | $5K | 2026-09-01 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 3,020 | $53.13 | $160K | 2026-08-18 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 519 | $54.20 | $28K | 2026-08-18 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 400 | $55.05 | $22K | 2026-08-18 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 3,100 | $49.29 | $153K | 2026-08-04 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 839 | $50.03 | $42K | 2026-08-04 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 6,278 | $50.80 | $319K | 2026-07-14 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 1,600 | $51.71 | $83K | 2026-07-14 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 7,878 | $49.08 | $387K | 2026-06-25 | 高管卖出, 减持超50%持仓 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 5,477 | $82.10 | $450K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 20 | $85.04 | $2K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 3,880 | $83.35 | $323K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 330 | $83.35 | $28K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 465 | $82.10 | $38K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 552 | $84.22 | $46K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | FMR LLC | - | 卖出 | 230 | $85.04 | $20K | 2026-01-15 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 35,512 | $48.16 | $1.7M | 2026-06-25 | 高管卖出, 百万级卖出 |
| ★★★★★(16) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 1,300 | $45.86 | $60K | 2026-09-01 | 高管卖出, 减持超20%持仓 |
| ★★★★★(0) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 4,008 | - | - | 2026-09-21 | |
| ★★★★★(0) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 12,024 | - | - | 2026-09-21 | |
| ★★★★★(0) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 10,626 | $11.67 | $124K | 2026-09-18 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 17,817 | - | - | 2026-09-01 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 5,939 | - | - | 2026-09-01 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 17,817 | $0.34 | $6K | 2026-09-01 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 11,817 | - | - | 2026-08-18 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 11,817 | $0.34 | $4K | 2026-08-18 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 3,939 | - | - | 2026-08-18 | |
| ★★★★★(0) | BERRIOS JOHN JOSEPH | Chief Commercial Officer | 卖出 | 140,766 | - | - | 2026-08-06 | |
| ★★★★★(0) | BERRIOS JOHN JOSEPH | Chief Commercial Officer | 卖出 | 174,612 | - | - | 2026-08-06 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 11,817 | $0.34 | $4K | 2026-08-04 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 3,939 | - | - | 2026-08-04 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 11,817 | - | - | 2026-08-04 | |
| ★★★★★(0) | FMR LLC | - | 卖出 | 0 | - | - | 2026-07-22 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 23,634 | - | - | 2026-07-14 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 23,634 | - | - | 2026-07-14 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 7,878 | - | - | 2026-07-14 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 23,634 | - | - | 2026-06-25 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 7,878 | - | - | 2026-06-25 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 23,634 | - | - | 2026-06-25 | |
| ★★★★★(0) | TETLOW SHARON | - | 卖出 | 39,453 | - | - | 2026-06-17 | |
| ★★★★★(0) | WELCH DANIEL G | - | 卖出 | 39,453 | - | - | 2026-06-17 | |
| ★★★★★(0) | DOBMEIER ERIC | - | 卖出 | 39,453 | - | - | 2026-06-17 | |
| ★★★★★(0) | LOVE TED W | - | 卖出 | 39,453 | - | - | 2026-06-17 | |
| ★★★★★(0) | WALDSTREICHER JOANNE | - | 卖出 | 39,453 | - | - | 2026-06-17 | |
| ★★★★★(0) | RUSSELL ANGUS C. | - | 卖出 | 39,453 | - | - | 2026-06-17 | |
| ★★★★★(0) | LANG MATTHEW | COO & GC | 卖出 | 223,776 | - | - | 2026-04-15 | |
| ★★★★★(0) | LANG MATTHEW | COO & GC | 卖出 | 184,614 | - | - | 2026-04-15 | |
| ★★★★★(0) | FMR LLC | - | 卖出 | 0 | - | - | 2026-04-14 | |
| ★★★★★(0) | YOON JUN | CHIEF FINANCIAL OFFICER | 卖出 | 104,085 | - | - | 2026-03-19 | |
| ★★★★★(0) | YOON JUN | CHIEF FINANCIAL OFFICER | 卖出 | 0 | - | - | 2026-03-19 | |
| ★★★★★(0) | HALL ASHLEY | Chief Development Officer | 卖出 | 59,073 | - | - | 2026-03-19 | |
| ★★★★★(0) | MA YINGLI | CHIEF TECHNOLOGY OFFICER | 卖出 | 32,526 | - | - | 2026-03-19 | |
| ★★★★★(0) | STEVENS RAYMOND C | CHIEF EXECUTIVE OFFICER | 卖出 | 322,230 | - | - | 2026-03-19 | |
| ★★★★★(0) | STEVENS RAYMOND C | CHIEF EXECUTIVE OFFICER | 卖出 | 260,217 | - | - | 2026-03-19 | |
| ★★★★★(0) | YOON JUN | CHIEF FINANCIAL OFFICER | 卖出 | 128,892 | - | - | 2026-03-19 | |
| ★★★★★(0) | MA YINGLI | CHIEF TECHNOLOGY OFFICER | 卖出 | 40,278 | - | - | 2026-03-19 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 43,368 | - | - | 2026-03-19 | |
| ★★★★★(0) | STEVENS RAYMOND C | CHIEF EXECUTIVE OFFICER | 卖出 | 0 | - | - | 2026-03-19 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 53,703 | - | - | 2026-03-19 | |
| ★★★★★(0) | HALL ASHLEY | Chief Development Officer | 卖出 | 47,706 | - | - | 2026-03-19 | |
| ★★★★★(0) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 93,984 | - | - | 2026-03-19 | |
| ★★★★★(0) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 75,897 | - | - | 2026-03-19 | |
| ★★★★★(0) | YOON JUN | CHIEF FINANCIAL OFFICER | 卖出 | 0 | - | - | 2026-03-03 | |
| ★★★★★(0) | STEVENS RAYMOND C | CHIEF EXECUTIVE OFFICER | 卖出 | 0 | - | - | 2026-03-03 | |
| ★★★★★(0) | MA YINGLI | CHIEF TECHNOLOGY OFFICER | 卖出 | 11,313 | $20.99 | $237K | 2026-03-03 | |
| ★★★★★(0) | COLL CRESPO BLAS | CHIEF MEDICAL OFFICER | 卖出 | 11,826 | $20.99 | $248K | 2026-03-03 | |
| ★★★★★(0) | LIN XICHEN | CHIEF SCIENTIFIC OFFICER | 卖出 | 18,735 | $20.99 | $393K | 2026-03-03 | |
| ★★★★★(0) | YOON JUN | CHIEF FINANCIAL OFFICER | 卖出 | 22,305 | $20.99 | $468K | 2026-03-03 | |
| ★★★★★(0) | STEVENS RAYMOND C | CHIEF EXECUTIVE OFFICER | 卖出 | 53,454 | $20.99 | $1.1M | 2026-03-03 | |
| ★★★★★(0) | HALL ASHLEY | Chief Development Officer | 卖出 | 4,836 | $20.99 | $102K | 2026-03-03 | |
| ★★★★★(0) | FMR LLC | - | 卖出 | 0 | - | - | 2026-01-15 |